Madeo, A <br/><br/>
c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells.  [electronic resource] 

 -  Oncogene  Feb 2010 
 - 978-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2009.400  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Breast Neoplasms--genetics<br/>Cell Death--drug effects<br/>Cell Line, Tumor<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>JNK Mitogen-Activated Protein Kinases--metabolism<br/>Organ Specificity<br/>Phosphorylation<br/>Promoter Regions, Genetic--genetics<br/>Proto-Oncogene Proteins c-fos--metabolism<br/>Proto-Oncogene Proteins c-jun--metabolism<br/>Receptors, Estrogen--analysis<br/>Substrate Specificity<br/>Tamoxifen--analogs & derivatives<br/>Transcription Factor AP-1--genetics<br/>Transcriptional Activation